National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.

VIVEbiotech is also collaborating with a range of different suppliers to make its operations as efficient as possible.

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...

XyloCor Therapeutics Inc., a Wayne gene therapy company, received $67.5 million from investors to support Phase 2 trials of a treatment designed to grow new blood vessels in the heart, XyloCor ...

Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...

In a finding with implications for one of the most promising cutting-edge medical treatments, researchers evaluated several ...

Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

UC San Diego Health one of a few health care systems on West Coast to offer new gene therapy for hemophilia B.

A new study published in the peer-reviewed journal Human Gene Therapy involved the generation of a human monoclonal antibody ...